Mode
Text Size
Log in / Sign up
Neurology 2026-W19 · Published Jun 4, 2026

This Week in Neurology: Stroke Interventions and Schizophrenia Findings

This week's research roundup begins with a systematic review published in Schizophrenia research that examined cerebrovascular changes in patients with the disorder. The study evaluated 11,611 patients and controls from international and Chinese databases, though the authors note inconclusive evidence regarding increased white matter hyperintensities or subcortical infarcts in schizophrenia relative to controls [1].

Meanwhile, attention turns to acute stroke management with a secondary analysis in Stroke and vascular neurology. Researchers evaluated remote ischaemic conditioning in 1717 patients with acute moderate ischaemic stroke. While the findings suggest a potential benefit for non-smokers, the authors describe this as a post hoc subgroup analysis and advise considering the intervention cautiously [2].

Elsewhere this week, a separate study in Topics in stroke rehabilitation investigated repetitive transcranial magnetic stimulation for managing post-stroke shoulder pain. This systematic review and meta-analysis evaluated rTMS in over 500 stroke survivors, with the authors suggesting that the therapy may reduce pain in the short term based on significant findings [3].

A separate analysis in Neurorehabilitation and neural repair looked at virtual reality applications, specifically semi-immersive VR for hand function in patients with hemiplegia after stroke. The meta-analysis of randomized controlled trials noted considerable heterogeneity when interpreting the benefits of this therapy for hand function [4].

Finally, we also saw research in CNS drugs regarding pharmacological interventions for acute ischemic stroke. A post hoc analysis of a phase 3 RCT involving 692 patients found no significant difference in excellent functional outcome at 90 days between argatroban plus alteplase and alteplase alone during the day. However, the authors suggest that argatroban plus alteplase may be associated with better nighttime stroke outcomes, though further validation is needed [5].

Articles in This Digest

Systematic review shows high prevalence of covert cerebrovascular changes in schizophrenia patients compared to controls Brain scans show hidden vessel changes in many people with schizophrenia
This systematic review and meta-analysis evaluated 11,611 patients with schizophrenia and controls from international and Chinese databases.
A large review found hidden signs of blood vessel issues in many people with schizophrenia, though experts urge caution before drawing firm conclusions.
Secondary Analysis Shows Remote Ischaemic Conditioning Benefit in Non-Smokers With Acute Ischaemic Stroke Trial shows stroke therapy increases recovery odds for non-smokers
This secondary analysis of a randomized controlled trial evaluated remote ischaemic conditioning in 1717 patients with acute moderate ischaemic stroke.
A stroke treatment called remote ischaemic conditioning helped more non-smokers recover well after three months compared to standard care.
Systematic review and meta-analysis shows rTMS reduces post-stroke shoulder pain in stroke survivors Magnetic pulses ease shoulder pain for stroke survivors
This systematic review and meta-analysis evaluated repetitive transcranial magnetic stimulation (rTMS) for post-stroke shoulder pain in over 500 stroke…
A new analysis of over 500 stroke survivors found magnetic pulses significantly reduced shoulder pain and improved movement compared to standard care.
Meta-analysis shows semi-immersive VR improves hand function in post-stroke patients with over 12 hours of therapy Virtual Reality Therapy Improves Hand Function After Stroke
This meta-analysis of randomized controlled trials evaluated virtual reality therapy for patients with hemiplegia after stroke.
A meta-analysis of trials shows virtual reality therapy significantly improves hand function in stroke patients, especially with longer treatment sessions.
Argatroban plus alteplase shows no daytime benefit but nighttime association with better stroke outcomes Stroke drug works better at night than in the morning
This post hoc analysis of a phase 3 RCT in 692 patients with acute ischemic stroke found no significant difference in excellent functional outcome at 90 days be…
Nighttime stroke treatment with argatroban plus alteplase may improve recovery, while daytime use showed no added benefit.
← 2026-W22 All Neurology digests →